<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/1354C618-9C7F-4E90-97AE-2A04B4C8536D"><gtr:id>1354C618-9C7F-4E90-97AE-2A04B4C8536D</gtr:id><gtr:name>Cancer Research UK (CRUK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850"><gtr:id>5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850</gtr:id><gtr:name>University of Strathclyde</gtr:name><gtr:department>Inst of Pharmacy and Biomedical Sci</gtr:department><gtr:address><gtr:line1>16 Richmond Street</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G1 1XQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850"><gtr:id>5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850</gtr:id><gtr:name>University of Strathclyde</gtr:name><gtr:address><gtr:line1>16 Richmond Street</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G1 1XQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/1354C618-9C7F-4E90-97AE-2A04B4C8536D"><gtr:id>1354C618-9C7F-4E90-97AE-2A04B4C8536D</gtr:id><gtr:name>Cancer Research UK (CRUK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/6320E2F3-F1F3-45E2-A767-ED0B6925536F"><gtr:id>6320E2F3-F1F3-45E2-A767-ED0B6925536F</gtr:id><gtr:firstName>Luke</gtr:firstName><gtr:otherNames>Haydn</gtr:otherNames><gtr:surname>Chamberlain</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/D88D7B18-8C60-4526-A8D0-AFF562796653"><gtr:id>D88D7B18-8C60-4526-A8D0-AFF562796653</gtr:id><gtr:firstName>Nicholas</gtr:firstName><gtr:otherNames>Charles</gtr:otherNames><gtr:surname>Tomkinson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/4F287ECE-2F1D-4E94-8C45-36EE01E5996F"><gtr:id>4F287ECE-2F1D-4E94-8C45-36EE01E5996F</gtr:id><gtr:firstName>Terry</gtr:firstName><gtr:surname>Smith</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=BB%2FL022087%2F1"><gtr:id>BDFE1057-E0E3-47F3-9427-940F6DFBF7F0</gtr:id><gtr:title>Fatty Acid Specificity in the DHHC Family of S-Acyltransferases: From Mechanisms to Functional Outcomes</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/L022087/1</gtr:grantReference><gtr:abstractText>The cells in our body contain a diverse array of different proteins that coordinate and drive specific pathways, such as cell growth and division. These proteins are subjected to strict modes of regulation to ensure that they are able to perform their specific functions as and when required. One prominent mechanism of protein regulation is via chemical modification and a variety of different molecules are added to proteins that affect their activity. One modification that is receiving increasing interest is &amp;quot;S-acylation&amp;quot;, the attachment of fatty acids onto proteins, which is catalysed by a family of twenty-four &amp;quot;DHHC&amp;quot; enzymes. Dysfunction of DHHC enzymes has been linked with many important disorders, including diabetes, Huntington's disease, schizophrenia, intellectual disability and cancer.

The fatty acids that are added to S-acylated proteins can be diverse and it is likely that different fatty acids affect proteins in different ways. Despite this, we currently know very little about the mechanisms that specify the chemical identity of fatty acids added to individual S-acylated proteins, and how fatty acid identity impacts protein function. Therefore the aim of this research is to promote a major advance in this poorly understood aspect of S-acylation. To do this, we have brought together experts in Chemistry and Biology with the goal of using novel chemical probes to determine: (a) if different DHHC enzymes preferentially add distinct types of fatty acids onto S-acylated proteins, (b) what features of DHHC enzymes underlie their fatty acid specificity, and (c) how different fatty acids affect the localisation of proteins to different regions of the cell and their function in specific cellular pathways. In addition to shedding light on an important but poorly understood aspect of cell biology, this research may also highlight new strategies to design selective modulators of DHHC enzymes to treat a range of clinical conditions.</gtr:abstractText><gtr:technicalSummary>S-acylation is a common post-translational modification that regulates a range of different cellular proteins and pathways. A recent major breakthrough in the S-acylation field was the discovery of a large family of &amp;quot;DHHC&amp;quot; enzymes that collectively mediate the bulk of cellular S-acylation reactions. S-acylation is often referred to as &amp;quot;palmitoylation&amp;quot; but, although palmitate is a major fatty acid incorporated into S-acylated proteins, quantitative methods have revealed that there can be considerable heterogeneity in the fatty acid profiles of S-acylated proteins. Furthermore, the chain length and degree of unsaturation of fatty acids is likely to have a major effect on the dynamics and functional activity of S-acylated proteins.

The aim of this project grant is to promote a major advance in our current understanding of how fatty acid heterogeneity in S-acylated proteins is generated and the functional consequences of this. To do this, we will employ a chemical-biology approach using a range of chemically synthesised azido and alkynyl fatty acids to define the fatty acid specificity of individual DHHC enzymes. Furthermore, we will utilise these fatty acid derivatives to determine how fatty acid specificity is encoded by the amino acid sequence of DHHC enzymes. Finally, we will investigate the effects that different fatty acids have on the trafficking and function of S-acylated proteins. Collectively, this research will promote a step change in our understanding of these poorly defined aspects of S-acylation and in the longer-term it may offer new opportunities for the development of selective modulators of DHHC enzymes.</gtr:technicalSummary><gtr:potentialImpactText>We envisage that the results of this project grant will not only benefit academics but will also impact the commercial and healthcare sectors and the general public. By identifying differences in fatty acid specificity within the DHHC family, we will highlight potential routes for the selective inhibition/modulation of individual DHHC enzymes by targeting the active site. As S-acylation and DHHC enzymes are potential novel drug targets for a range of important disorders, this is likely to attract interest and potentially investment from pharmaceutical companies. The results are also likely to be of interest to clinicians studying the disorders linked with DHHC enzyme dysfunction. The time-scale for these impacts is short-to-medium term (possibly within the time frame of the grant). 

Other beneficiaries of the research will be the general public. A longer term impact (10-15 years) may be on patients suffering from disorders associated with dysfunctional S-acylation if the results of the study open new avenues for selective modulation of DHHC enzymes. A shorter-term impact (during the grant) will be on local schoolchildren- we play a prominent role interacting with schoolchildren by accepting pupils on work experience placements and participating in university open days, science fairs and school visits. This will hopefully allow us to inspire a future generation of biomedical scientists. In relation to the current project, we think there is a great opportunity to highlight the importance of other scientific disciplines (e.g. chemistry) in advancing our understanding of biomedical science. Another societal impact of the research will be the high-quality training that the post-doctoral research assistants will receive, enhancing the skills base of the UK and our global competitiveness.</gtr:potentialImpactText><gtr:fund><gtr:end>2018-05-06</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2014-09-30</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>460840</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cancer Research UK (CRUK)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>The Beatson Institute for Cancer Research</gtr:department><gtr:description>S-acylation partnership, Beatson Institute</gtr:description><gtr:id>70EAAF45-C6F2-4E21-8BC5-2FCD1454A7AA</gtr:id><gtr:impact>Not yet</gtr:impact><gtr:partnerContribution>Intellectual input and supporting background experimental data.</gtr:partnerContribution><gtr:piContribution>Collaboration developed using expertise established in my lab to study S-acylation of specific target proteins using fatty acid azide derivatives and click chemistry.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sheffield</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>S-acylation partnership, University of Sheffield</gtr:description><gtr:id>896FF7EA-0E40-447F-A3D9-2E4E308CAEED</gtr:id><gtr:impact>not yet</gtr:impact><gtr:partnerContribution>Intellectual input and supporting experimental data</gtr:partnerContribution><gtr:piContribution>Collaboration developed using expertise established in my lab to study S-acylation of specific target proteins using fatty acid azide derivatives and click chemistry.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>school science project</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>7994A255-790C-4A03-BF76-31721234DBAB</gtr:id><gtr:impact>12 school pupils (age 15-16) and their teacher visited our laboratory to learn more about our research related to neurodegeneration. There was both a theoretical and a practical component. Several pupils reported an interest in pursuing a higher degree in biology-related subjects and this was reinforced by the visit. The school has also reported that they would be interested in participating in this event again.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>345000</gtr:amountPounds><gtr:country>Japan</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Funding from pharmaceutical company</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>Ono Pharmaceutical</gtr:fundingOrg><gtr:id>ADA6EB7B-E8C4-4DA5-A33A-6CEABC3CD34F</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2015-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>62000</gtr:amountPounds><gtr:country>Japan</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Porject grant</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>Ono Pharmaceutical</gtr:fundingOrg><gtr:id>9C874435-66E1-4B7F-AC5E-68DFB5B7D3A8</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have profiled the fatty acid selectivities of a large number of zDHHC enzymes using fatty acid azides and click chemistry. This work has shown that individual enzymes have distinct preferences for specific chain length fatty acids. Furthermore, we have uncovered the molecular basis for these differences in fatty acid selectivity. This work is the first description of how the fatty acid selectivity of zDHHC enzymes is achieved. The work is currently being prepared for publication.</gtr:description><gtr:exploitationPathways>A major outstanding question relates to the functional outcomes of protein modification by different types of fatty acid; this is currently being addressed.</gtr:exploitationPathways><gtr:id>24A59CDE-D71E-42BE-A63D-1A954FF739F5</gtr:id><gtr:sectors><gtr:sector>Healthcare</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Azide/alkyne derivatives of different fatty acids have been developed to assay the fatty acid selectivity of enzymes involves in S-acylation.</gtr:description><gtr:id>1216A2BC-202C-4F12-89F3-97A562F744B8</gtr:id><gtr:impact>manuscripts in preparation</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Azide and alkyne derivatives of fatty acids for analysis of S-acylation by click chemistry</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Wild-type and cysteine mutant forms of EGFP-tagged caveolin-1 and caveolin-2 were generated (mouse). These are suitable for studying the function of caveolins in mouse adipocyte cultures.</gtr:description><gtr:id>0721A60D-29C7-47F0-8E17-1D22D94E86FB</gtr:id><gtr:impact>Manuscript in preparation</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>EGFP-tagged Caveolin proteins and associated mutants</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DABD6E09-7712-4A12-8244-868B0C0270D5"><gtr:id>DABD6E09-7712-4A12-8244-868B0C0270D5</gtr:id><gtr:title>Molecular basis of fatty acid selectivity in the zDHHC family of S-acyltransferases revealed by click chemistry.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4bd270b0af5849b1fe8eb6144c246475"><gtr:id>4bd270b0af5849b1fe8eb6144c246475</gtr:id><gtr:otherNames>Greaves J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/483CC61C-1A17-47E5-AD09-1CF6B99F804C"><gtr:id>483CC61C-1A17-47E5-AD09-1CF6B99F804C</gtr:id><gtr:title>A cluster of palmitoylated cysteines are essential for aggregation of cysteine-string protein mutants that cause neuronal ceroid lipofuscinosis.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5db9803c29435690c225c984a30543de"><gtr:id>5db9803c29435690c225c984a30543de</gtr:id><gtr:otherNames>Diez-Ardanuy C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/00EF1D77-88D2-4951-9D6F-440B99384C1D"><gtr:id>00EF1D77-88D2-4951-9D6F-440B99384C1D</gtr:id><gtr:title>Obesogenic and Diabetogenic Effects of High-Calorie Nutrition Require Adipocyte BK Channels.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f4ca4a130b4a845adc0e5e97a49db9ab"><gtr:id>f4ca4a130b4a845adc0e5e97a49db9ab</gtr:id><gtr:otherNames>Illison J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/L022087/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>F442B6BE-8B89-4C01-8D3B-E8A4D320B672</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Biomolecules &amp; biochemistry</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>A442BF36-F335-483E-9282-F3BB48AC2C47</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Cell biology</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>649031FD-C21E-42D9-AC12-41ACA59CC11C</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Biochemistry &amp; physiology</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>D22AE401-1C35-4706-A19C-10861ABC82CD</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Biological membranes</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>02567418-12CB-462E-9092-530C6E63B359</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Chemical Biology</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>73EF98E1-3FA8-46A0-BE46-00AE16C7D999</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Communication &amp; signalling</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>1163A5D2-CE35-4C7E-904E-6FB2B5FA0C2A</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Multiprotein complexes</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>